ChemPartner has developed cutting-edge technologies to provide excellent services for drug discovery programs. Our staff possesses biotechnology and pharmaceutical R&D experience to understand your needs and meet your requirements.
By utilizing our biomarker strategies, our customers are able to benefit significantly from our well-developed technologies and move their projects forward faster. For example, the NanoPro platform enables quantification of protein phosphorylation in very small samples, such as biopsies & stem cells. FISH allows the detection of HER2 amplification in cell lines as well as in patient samples. Overall, we strive to provide excellent service to support our clients’ drug discovery and translational medicine needs.